Jung-Mao Hsu

Jung-Mao Hsu

China Medical University

H-index: 42

Asia-China

About Jung-Mao Hsu

Jung-Mao Hsu, With an exceptional h-index of 42 and a recent h-index of 36 (since 2020), a distinguished researcher at China Medical University, specializes in the field of Cancer Biology, Immunotherapy.

His recent articles reflect a diverse array of research interests and contributions to the field:

Gasdermins and cancers

Inhibition of Galectin-9 sensitizes tumors to anthracycline treatment via inducing antitumor immunity

Nuclear export signal mutation of epidermal growth factor receptor enhances malignant phenotypes of cancer cells

Erratum to'Ribonuclease 7-driven activation of ROS1 is a potential therapeutic target in hepatocellular carcinoma'[J Hepatol 2021 (907-918)]

Phosphorylation and stabilization of PD-L1 by CK2 suppresses dendritic cell function

The Ohio vaccine lottery and starting vaccination rates

Mechanisms regulating PD-L1 expression in cancers and associated opportunities for novel small-molecule therapeutics

Method and a kit for predicting the susceptibility to stimulator of interferon genes (sting) agonists in a cancer patient

Jung-Mao Hsu Information

University

Position

Taiwan

Citations(all)

10529

Citations(since 2020)

7083

Cited By

5638

hIndex(all)

42

hIndex(since 2020)

36

i10Index(all)

53

i10Index(since 2020)

52

Email

University Profile Page

China Medical University

Google Scholar

View Google Scholar Profile

Jung-Mao Hsu Skills & Research Interests

Cancer Biology

Immunotherapy

Top articles of Jung-Mao Hsu

Title

Journal

Author(s)

Publication Date

Gasdermins and cancers

Junwei Hou

Tiansheng Li

Jung-Mao Hsu

Xin Zhang

Mien-Chie Hung

2023/11/1

Inhibition of Galectin-9 sensitizes tumors to anthracycline treatment via inducing antitumor immunity

International Journal of Biological Sciences

Xian Sun

Wei-Jan Wang

Jilu Lang

Riyao Yang

Wan-Jou Shen

...

2023

Nuclear export signal mutation of epidermal growth factor receptor enhances malignant phenotypes of cancer cells

American Journal of Cancer Research

Lei Nie

Ying-Nai Wang

Jung-Mao Hsu

Junwei Hou

Yu-Yi Chu

...

2023

Erratum to'Ribonuclease 7-driven activation of ROS1 is a potential therapeutic target in hepatocellular carcinoma'[J Hepatol 2021 (907-918)]

Journal of hepatology

Chunxiao Liu

Zhengyu Zha

Chenhao Zhou

Yeh Chen

Weiya Xia

...

2022/8

Phosphorylation and stabilization of PD-L1 by CK2 suppresses dendritic cell function

Cancer Research

Xixi Zhao

Yongkun Wei

Yu-Yi Chu

Yintao Li

Jung-Mao Hsu

...

2022/6/6

The Ohio vaccine lottery and starting vaccination rates

American Journal of Health Economics

Margaret E Brehm

Paul A Brehm

Martin Saavedra

2022/6/1

Mechanisms regulating PD-L1 expression in cancers and associated opportunities for novel small-molecule therapeutics

Hirohito Yamaguchi

Jung-Mao Hsu

Wen-Hao Yang

Mien-Chie Hung

2022/2/7

Method and a kit for predicting the susceptibility to stimulator of interferon genes (sting) agonists in a cancer patient

2022/11/17

Deglycosylation of SLAMF7 in breast cancers enhances phagocytosis

American Journal of Cancer Research

Shih-Han Wang

Wen-Cheng Chou

Hsiang-Chi Huang

Te-An Lee

Tzu-Chun Hsiao

...

2022

Detection of arginine methylation of EGFR for prediction of resistance to therapy

2022/9/27

Targeting conserved N-glycosylation blocks SARS-CoV-2 variant infection in vitro

EBioMedicine

Hsiang-Chi Huang

Yun-Ju Lai

Chun-Che Liao

Feng-Yang Wang

Ke-Bin Huang

...

2021/12/1

Ribonuclease 7-driven activation of ROS1 is a potential therapeutic target in hepatocellular carcinoma

Journal of hepatology

Chunxiao Liu

Zhengyu Zha

Chenhao Zhou

Yeh Chen

Weiya Xia

...

2021/4/1

Molecular mechanisms and functions of pyroptosis in inflammation and antitumor immunity

Junwei Hou

Jung-Mao Hsu

Mien-Chie Hung

2021/11/18

Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy

Nature communications

Riyao Yang

Linlin Sun

Ching-Fei Li

Yu-Han Wang

Jun Yao

...

2021/2/5

Activated T cell-derived exosomal PD-1 attenuates PD-L1-induced immune dysfunction in triple-negative breast cancer

Oncogene

Yufan Qiu

Yi Yang

Riyao Yang

Chunxiao Liu

Jung-Mao Hsu

...

2021/8/5

Hyperglycosylated spike of SARS-CoV-2 gamma variant induces breast cancer metastasis

American journal of cancer research

Hsiang-Chi Huang

Chun-Che Liao

Shih-Han Wang

I-Jung Lee

Te-An Lee

...

2021

The N-linked glycosylations of TIGIT Asn32 and Asn101 facilitate PVR/TIGIT interaction

Biochemical and Biophysical Research Communications

Yu-Xi Lin

Mien-Chie Hung

Jye-Lin Hsu

Jung-Mao Hsu

2021/7/12

Epithelial-mesenchymal transition induced by SARS-CoV-2 required transcriptional upregulation of Snail

American journal of cancer research

Yun-Ju Lai

Chi-Hong Chao

Chun-Che Liao

Te-An Lee

Jung-Mao Hsu

...

2021

TYRO3 induces anti–PD-1/PD-L1 therapy resistance by limiting innate immunity and tumoral ferroptosis

Journal of Clinical Investigation

Zhou Jiang

Seung-Oe Lim

Meisi Yan

Jennifer L Hsu

Jun Yao

...

2021/4/15

Author Correction: CDK2-mediated site-specific phosphorylation of EZH2 drives and maintains triple-negative breast cancer

Nature communications

Lei Nie

Yongkun Wei

Fei Zhang

Yi-Hsin Hsu

Li-Chuan Chan

...

2020

See List of Professors in Jung-Mao Hsu University(China Medical University)

Co-Authors

H-index: 169
Mien-Chie Hung

Mien-Chie Hung

China Medical University

H-index: 51
Hirohito Yamaguchi

Hirohito Yamaguchi

China Medical University

H-index: 34
Seung Oe Lim

Seung Oe Lim

Purdue University

H-index: 31
Hui-Lung Sun

Hui-Lung Sun

University of Chicago

H-index: 30
Jer-Yen Yang

Jer-Yen Yang

Purdue University

H-index: 23
Jong-Ho cha

Jong-Ho cha

Inha University

academic-engine